Fuqing Hu

2.4k total citations · 2 hit papers
20 papers, 1.3k citations indexed

About

Fuqing Hu is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Fuqing Hu has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Fuqing Hu's work include Epigenetics and DNA Methylation (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Autophagy in Disease and Therapy (3 papers). Fuqing Hu is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Autophagy in Disease and Therapy (3 papers). Fuqing Hu collaborates with scholars based in China and United States. Fuqing Hu's co-authors include Junbo Hu, Xuelai Luo, Guihua Wang, Zhenlin Hou, Da Song, Jingqin Lan, Feng Xu, Lu Liu, Xianglin Yuan and Li Sun and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Fuqing Hu

20 papers receiving 1.3k citations

Hit Papers

M2 Macrophage-Derived Exosomes Promote Cell Migration and... 2018 2026 2020 2023 2018 2021 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fuqing Hu China 16 873 449 304 242 196 20 1.3k
Ming Zhong China 20 838 1.0× 571 1.3× 187 0.6× 382 1.6× 156 0.8× 56 1.4k
Kaisa Cui China 21 864 1.0× 532 1.2× 279 0.9× 257 1.1× 121 0.6× 37 1.2k
Hanxiang Zhan China 20 573 0.7× 394 0.9× 174 0.6× 420 1.7× 151 0.8× 41 1.1k
Yongfu Zhao China 24 923 1.1× 529 1.2× 301 1.0× 261 1.1× 139 0.7× 60 1.5k
Nan You China 19 656 0.8× 410 0.9× 97 0.3× 250 1.0× 172 0.9× 61 1.3k
Surui Yao China 19 1.2k 1.3× 964 2.1× 290 1.0× 269 1.1× 114 0.6× 41 1.6k
Wenfang Tian China 17 588 0.7× 152 0.3× 296 1.0× 247 1.0× 232 1.2× 34 1.1k
Xiaowu Xu China 23 1.0k 1.2× 629 1.4× 176 0.6× 531 2.2× 226 1.2× 82 1.7k
Estelle Saland France 18 902 1.0× 329 0.7× 173 0.6× 179 0.7× 232 1.2× 28 1.4k
Bojian Fei China 21 1.5k 1.8× 1.4k 3.1× 295 1.0× 370 1.5× 170 0.9× 55 2.1k

Countries citing papers authored by Fuqing Hu

Since Specialization
Citations

This map shows the geographic impact of Fuqing Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuqing Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuqing Hu more than expected).

Fields of papers citing papers by Fuqing Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuqing Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuqing Hu. The network helps show where Fuqing Hu may publish in the future.

Co-authorship network of co-authors of Fuqing Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Fuqing Hu. A scholar is included among the top collaborators of Fuqing Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuqing Hu. Fuqing Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jiakun, Fuqing Hu, Da Song, et al.. (2024). ETHE1 dampens colorectal cancer angiogenesis by promoting TC45 Dephosphorylation of STAT3 to inhibit VEGF-A expression. Cell Death and Disease. 15(8). 631–631. 3 indexed citations
2.
Wu, Qi, Zhihong Wang, Siqi Chen, et al.. (2024). USP26 promotes colorectal cancer tumorigenesis by restraining PRKN-mediated mitophagy. Oncogene. 43(21). 1581–1593. 7 indexed citations
3.
Song, Da, Fuqing Hu, Changsheng Huang, et al.. (2023). Tiam1 methylation by NSD2 promotes Rac1 signaling activation and colon cancer metastasis. Proceedings of the National Academy of Sciences. 120(52). e2305684120–e2305684120. 9 indexed citations
4.
Ren, Shengxiang, Yaqi Chen, Anyi Liu, et al.. (2023). PD-L1 methylation restricts PD-L1/PD-1 interactions to control cancer immune surveillance. Science Advances. 9(21). eade4186–eade4186. 40 indexed citations
5.
Huang, Changsheng, Fuqing Hu, Da Song, et al.. (2022). EZH2-triggered methylation of SMAD3 promotes its activation and tumor metastasis. SHILAP Revista de lepidopterología. 31 indexed citations
6.
Hu, Fuqing, Da Song, Yumeng Yan, et al.. (2021). IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation. Nature Communications. 12(1). 3651–3651. 168 indexed citations breakdown →
7.
Ren, Huihui, Fuqing Hu, Dan Wang, et al.. (2021). Sirtuin 2 Prevents Liver Steatosis and Metabolic Disorders by Deacetylation of Hepatocyte Nuclear Factor 4α. Hepatology. 74(2). 723–740. 70 indexed citations
8.
Wang, Guihua, Fuqing Hu, Feng Xu, et al.. (2021). Correction: Loss of BRG1 induces CRC cell senescence by regulating p53/p21 pathway. Cell Death and Disease. 12(10). 895–895. 1 indexed citations
9.
Hou, Zhenlin, Li Sun, Feng Xu, et al.. (2020). Blocking histone methyltransferase SETDB1 inhibits tumorigenesis and enhances cetuximab sensitivity in colorectal cancer. Cancer Letters. 487. 63–73. 29 indexed citations
10.
Hu, Fuqing, Li Geng, Changsheng Huang, et al.. (2020). The autophagy-independent role of BECN1 in colorectal cancer metastasis through regulating STAT3 signaling pathway activation. Cell Death and Disease. 11(5). 304–304. 52 indexed citations
11.
Sun, Xuling, Fuqing Hu, Zhenlin Hou, et al.. (2019). SIX4 activates Akt and promotes tumor angiogenesis. Experimental Cell Research. 383(1). 111495–111495. 22 indexed citations
12.
Lan, Jingqin, Li Sun, Feng Xu, et al.. (2018). M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer. Cancer Research. 79(1). 146–158. 515 indexed citations breakdown →
13.
Yang, Xi, et al.. (2018). PIK3R3 regulates PPARα expression to stimulate fatty acid β-oxidation and decrease hepatosteatosis. Experimental & Molecular Medicine. 50(1). e431–e431. 38 indexed citations
14.
Hu, Fuqing, Haijie Li, Lu Liu, et al.. (2018). Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1β/VEGFA signalling. Molecular Cancer. 17(1). 107–107. 39 indexed citations
15.
Hou, Zhenlin, Xuling Sun, Fuqing Hu, et al.. (2018). TRIB2 functions as novel oncogene in colorectal cancer by blocking cellular senescence through AP4/p21 signaling. Molecular Cancer. 17(1). 172–172. 68 indexed citations
16.
Hu, Fuqing, Xuling Sun, Geng Li, et al.. (2018). Inhibition of SIRT2 limits tumour angiogenesis via inactivation of the STAT3/VEGFA signalling pathway. Cell Death and Disease. 10(1). 80 indexed citations
17.
Li, Guodong, Fuqing Hu, Zhenlin Hou, et al.. (2018). PIK3R3 promotes chemotherapeutic sensitivity of colorectal cancer through PIK3R3 /NF-kB/TP pathway. Cancer Biology & Therapy. 19(3). 222–229. 15 indexed citations
18.
Wang, Guihua, Fuqing Hu, Feng Xu, et al.. (2017). Loss of BRG1 induces CRC cell senescence by regulating p53/p21 pathway. Cell Death and Disease. 8(2). e2607–e2607. 48 indexed citations
19.
Li, Guodong, Fuqing Hu, Xuelai Luo, Junbo Hu, & Yongdong Feng. (2017). SIX4 promotes metastasis via activation of the PI3K-AKT pathway in colorectal cancer. PeerJ. 5. e3394–e3394. 31 indexed citations
20.
Zhang, Meng, Jin Huang, Cheng He, et al.. (2017). Transmembrane TNF-α promotes activation-induced cell death by forward and reverse signaling. Oncotarget. 8(38). 63799–63812. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026